Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 25 to 36 of 46 entries
Sorted by: Best Match Show Resources per page
Immunological, hematological, biochemical, and histopathological studies on cows naturally infected with lumpy skin disease.

Veterinary world

Neamat-Allah AN.
PMID: 27047209
Vet World. 2015 Sep;8(9):1131-6. doi: 10.14202/vetworld.2015.1131-1136. Epub 2015 Sep 23.

AIM: Lumpy skin disease (LSD) is an infectious viral disease of cattle caused by LSD virus (LSDV) of the family Poxviridae characterized by skin nodules covering all parts of the body. There are many aspects of LSD remaining unknown,...

Cite
Neamat-Allah AN. Immunological, hematological, biochemical, and histopathological studies on cows naturally infected with lumpy skin disease. Vet World. 2015;8(9):1131-6doi: 10.14202/vetworld.2015.1131-1136.
Neamat-Allah, A. N. (2015). Immunological, hematological, biochemical, and histopathological studies on cows naturally infected with lumpy skin disease. Veterinary world, 8(9), 1131-6. https://doi.org/10.14202/vetworld.2015.1131-1136
Neamat-Allah, Ahmed N F. "Immunological, hematological, biochemical, and histopathological studies on cows naturally infected with lumpy skin disease." Veterinary world vol. 8,9 (2015): 1131-6. doi: https://doi.org/10.14202/vetworld.2015.1131-1136
Neamat-Allah AN. Immunological, hematological, biochemical, and histopathological studies on cows naturally infected with lumpy skin disease. Vet World. 2015 Sep;8(9):1131-6. doi: 10.14202/vetworld.2015.1131-1136. Epub 2015 Sep 23. PMID: 27047209; PMCID: PMC4774783.
Copy Download .nbib Format: NLM
Different Immune Responses in Dangerous O Blood Donors.

Iranian journal of pathology

Arabi S, Moghaddam M, Maleki V, Pourfathollah AA, Aghaie A.
PMID: 32095148
Iran J Pathol. 2020;15(1):34-40. doi: 10.30699/IJP.2019.77233.1728.

BACKGROUND & OBJECTIVE: Dangerous O is very important to transfusion medicine and there has been reports by Food and Drug Administration (FDA) regarding some death relating incidences. As high iso-antibody production is closely associated with different immune reactions, a...

Cite
Arabi S, Moghaddam M, Maleki V, et al. Different Immune Responses in Dangerous O Blood Donors. Iran J Pathol. 2020;15(1):34-40doi: 10.30699/IJP.2019.77233.1728.
Arabi, S., Moghaddam, M., Maleki, V., Pourfathollah, A. A., & Aghaie, A. (2020). Different Immune Responses in Dangerous O Blood Donors. Iranian journal of pathology, 15(1), 34-40. https://doi.org/10.30699/IJP.2019.77233.1728
Arabi, Shaghayegh, et al. "Different Immune Responses in Dangerous O Blood Donors." Iranian journal of pathology vol. 15,1 (2020): 34-40. doi: https://doi.org/10.30699/IJP.2019.77233.1728
Arabi S, Moghaddam M, Maleki V, Pourfathollah AA, Aghaie A. Different Immune Responses in Dangerous O Blood Donors. Iran J Pathol. 2020;15(1):34-40. doi: 10.30699/IJP.2019.77233.1728. PMID: 32095148; PMCID: PMC6995684.
Copy Download .nbib Format: NLM
Ratio of the Fab fragments I and II from goat antibodies normal gamma-globulins.

FEBS letters

Strosberg AD, Kanarek L.
PMID: 11947327
FEBS Lett. 1970 Jan 15;6(1):28-30. doi: 10.1016/0014-5793(70)80033-3.

No abstract available.

Cite
Strosberg AD, Kanarek L. Ratio of the Fab fragments I and II from goat antibodies normal gamma-globulins. FEBS Lett. 1970;6(1):28-30doi: 10.1016/0014-5793(70)80033-3.
Strosberg, A. D., & Kanarek, L. (1970). Ratio of the Fab fragments I and II from goat antibodies normal gamma-globulins. FEBS letters, 6(1), 28-30. https://doi.org/10.1016/0014-5793(70)80033-3
Strosberg, A D., and Kanarek, L. "Ratio of the Fab fragments I and II from goat antibodies normal gamma-globulins." FEBS letters vol. 6,1 (1970): 28-30. doi: https://doi.org/10.1016/0014-5793(70)80033-3
Strosberg AD, Kanarek L. Ratio of the Fab fragments I and II from goat antibodies normal gamma-globulins. FEBS Lett. 1970 Jan 15;6(1):28-30. doi: 10.1016/0014-5793(70)80033-3. PMID: 11947327.
Copy Download .nbib Format: NLM
STUDIES ON HUMAN PROTEINURIA. II. SOME CHARACTERISTICS OF THE GAMMA GLOBULINS EXCRETED IN NORMAL, EXERCISE, POSTURAL, AND NEPHROTIC PROTEINURIA.

The Journal of clinical investigation

McKay E, Slater RJ.
PMID: 16695881
J Clin Invest. 1962 Aug;41(8):1638-52. doi: 10.1172/JCI104621.

No abstract available.

Cite
McKay E, Slater RJ. STUDIES ON HUMAN PROTEINURIA. II. SOME CHARACTERISTICS OF THE GAMMA GLOBULINS EXCRETED IN NORMAL, EXERCISE, POSTURAL, AND NEPHROTIC PROTEINURIA. J Clin Invest. 1962;41(8):1638-52doi: 10.1172/JCI104621.
McKay, E., & Slater, R. J. (1962). STUDIES ON HUMAN PROTEINURIA. II. SOME CHARACTERISTICS OF THE GAMMA GLOBULINS EXCRETED IN NORMAL, EXERCISE, POSTURAL, AND NEPHROTIC PROTEINURIA. The Journal of clinical investigation, 41(8), 1638-52. https://doi.org/10.1172/JCI104621
McKay, E, and Slater, R J. "STUDIES ON HUMAN PROTEINURIA. II. SOME CHARACTERISTICS OF THE GAMMA GLOBULINS EXCRETED IN NORMAL, EXERCISE, POSTURAL, AND NEPHROTIC PROTEINURIA." The Journal of clinical investigation vol. 41,8 (1962): 1638-52. doi: https://doi.org/10.1172/JCI104621
McKay E, Slater RJ. STUDIES ON HUMAN PROTEINURIA. II. SOME CHARACTERISTICS OF THE GAMMA GLOBULINS EXCRETED IN NORMAL, EXERCISE, POSTURAL, AND NEPHROTIC PROTEINURIA. J Clin Invest. 1962 Aug;41(8):1638-52. doi: 10.1172/JCI104621. PMID: 16695881; PMCID: PMC291081.
Copy Download .nbib Format: NLM
Vaccination against rheumatoid arthritis: concepts and progress.

BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy

Moreland LW, Koopman WJ.
PMID: 18020497
BioDrugs. 1997 Aug;8(2):87-95. doi: 10.2165/00063030-199708020-00002.

Recently, interest has grown in the potential benefit of vaccination approaches in humans with rheumatoid arthritis. Approaches evaluated include the use of T cell receptor peptide vaccines, autologous T cells, major histocompatibility complex (MHC) peptides, allogeneic mononuclear cells and...

Cite
Moreland LW, Koopman WJ. Vaccination against rheumatoid arthritis: concepts and progress. BioDrugs. 1997;8(2):87-95doi: 10.2165/00063030-199708020-00002.
Moreland, L. W., & Koopman, W. J. (1997). Vaccination against rheumatoid arthritis: concepts and progress. BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy, 8(2), 87-95. https://doi.org/10.2165/00063030-199708020-00002
Moreland, L W, and Koopman, W J. "Vaccination against rheumatoid arthritis: concepts and progress." BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy vol. 8,2 (1997): 87-95. doi: https://doi.org/10.2165/00063030-199708020-00002
Moreland LW, Koopman WJ. Vaccination against rheumatoid arthritis: concepts and progress. BioDrugs. 1997 Aug;8(2):87-95. doi: 10.2165/00063030-199708020-00002. PMID: 18020497.
Copy Download .nbib Format: NLM
THE SYNTHESIS AND SECRETION OF gamma-GLOBULINS BY LYMPH NODE CELLS, I. THE MICROSOMAL COMPARTMENTALIZATION OF gamma-GLOBULINS.

Proceedings of the National Academy of Sciences of the United States of America

Swenson RM, Kern M.
PMID: 16591486
Proc Natl Acad Sci U S A. 1967 Feb;57(2):417-22. doi: 10.1073/pnas.57.2.417.

No abstract available.

Cite
Swenson RM, Kern M. THE SYNTHESIS AND SECRETION OF gamma-GLOBULINS BY LYMPH NODE CELLS, I. THE MICROSOMAL COMPARTMENTALIZATION OF gamma-GLOBULINS. Proc Natl Acad Sci U S A. 1967;57(2):417-22doi: 10.1073/pnas.57.2.417.
Swenson, R. M., & Kern, M. (1967). THE SYNTHESIS AND SECRETION OF gamma-GLOBULINS BY LYMPH NODE CELLS, I. THE MICROSOMAL COMPARTMENTALIZATION OF gamma-GLOBULINS. Proceedings of the National Academy of Sciences of the United States of America, 57(2), 417-22. https://doi.org/10.1073/pnas.57.2.417
Swenson, R M, and Kern, M. "THE SYNTHESIS AND SECRETION OF gamma-GLOBULINS BY LYMPH NODE CELLS, I. THE MICROSOMAL COMPARTMENTALIZATION OF gamma-GLOBULINS." Proceedings of the National Academy of Sciences of the United States of America vol. 57,2 (1967): 417-22. doi: https://doi.org/10.1073/pnas.57.2.417
Swenson RM, Kern M. THE SYNTHESIS AND SECRETION OF gamma-GLOBULINS BY LYMPH NODE CELLS, I. THE MICROSOMAL COMPARTMENTALIZATION OF gamma-GLOBULINS. Proc Natl Acad Sci U S A. 1967 Feb;57(2):417-22. doi: 10.1073/pnas.57.2.417. PMID: 16591486; PMCID: PMC335522.
Copy Download .nbib Format: NLM
Separation of gamma-globulins from porcine plasma by reversed micellar extraction.

Journal of bioscience and bioengineering

Yang TH, Yet MG, Hsu CK, Chiang BH.
PMID: 16233086
J Biosci Bioeng. 2001;92(3):214-20. doi: 10.1263/jbb.92.214.

Factors affecting the separation of gamma-globulins from porcine plasma using reversed micelles were screened based on a fractional factorial design. The optimal processing conditions for obtaining the maximum yield of gamma-globulins under various constraints of product purity were determined...

Cite
Yang TH, Yet MG, Hsu CK, et al. Separation of gamma-globulins from porcine plasma by reversed micellar extraction. J Biosci Bioeng. 2001;92(3):214-20doi: 10.1263/jbb.92.214.
Yang, T. H., Yet, M. G., Hsu, C. K., & Chiang, B. H. (2001). Separation of gamma-globulins from porcine plasma by reversed micellar extraction. Journal of bioscience and bioengineering, 92(3), 214-20. https://doi.org/10.1263/jbb.92.214
Yang, T H, et al. "Separation of gamma-globulins from porcine plasma by reversed micellar extraction." Journal of bioscience and bioengineering vol. 92,3 (2001): 214-20. doi: https://doi.org/10.1263/jbb.92.214
Yang TH, Yet MG, Hsu CK, Chiang BH. Separation of gamma-globulins from porcine plasma by reversed micellar extraction. J Biosci Bioeng. 2001;92(3):214-20. doi: 10.1263/jbb.92.214. PMID: 16233086.
Copy Download .nbib Format: NLM
Sequential bilateral central retinal vein occlusions in a cystic fibrosis patient with hyperhomocysteinemia and hypergamma-globulinemia.

Retinal cases & brief reports

Gelman R, DiMango EA, Schiff WM.
PMID: 24404207
Retin Cases Brief Rep. 2013;7(4):362-7. doi: 10.1097/ICB.0b013e3182965271.

PURPOSE: To report a case of sequential bilateral central retinal vein occlusions in a cystic fibrosis patient with hyperhomocysteinemia and hypergamma-globulinemia over 6 years of follow up.METHODS: Observational case report of one patient.RESULTS: A 31 year-old male with a...

Cite
Gelman R, DiMango EA, Schiff WM. Sequential bilateral central retinal vein occlusions in a cystic fibrosis patient with hyperhomocysteinemia and hypergamma-globulinemia. Retin Cases Brief Rep. 2013;7(4):362-7doi: 10.1097/ICB.0b013e3182965271.
Gelman, R., DiMango, E. A., & Schiff, W. M. (2013). Sequential bilateral central retinal vein occlusions in a cystic fibrosis patient with hyperhomocysteinemia and hypergamma-globulinemia. Retinal cases & brief reports, 7(4), 362-7. https://doi.org/10.1097/ICB.0b013e3182965271
Gelman, Rony, et al. "Sequential bilateral central retinal vein occlusions in a cystic fibrosis patient with hyperhomocysteinemia and hypergamma-globulinemia." Retinal cases & brief reports vol. 7,4 (2013): 362-7. doi: https://doi.org/10.1097/ICB.0b013e3182965271
Gelman R, DiMango EA, Schiff WM. Sequential bilateral central retinal vein occlusions in a cystic fibrosis patient with hyperhomocysteinemia and hypergamma-globulinemia. Retin Cases Brief Rep. 2013;7(4):362-7. doi: 10.1097/ICB.0b013e3182965271. PMID: 24404207; PMCID: PMC3882319.
Copy Download .nbib Format: NLM
Monoclonal antibodies to a higher-plant nitrate reductase: Differential inhibition of enzyme activities.

Planta

Notton BA, Fido RJ, Galfre G.
PMID: 24240965
Planta. 1985 Jul;165(1):114-9. doi: 10.1007/BF00392219.

A set of monoclonal antibodies has been raised against NADH-nitrate reductase (NR; EC 1.6.6.1) from spinach (Spinacea oleracea L.) leaves. Antibodies were screened by enzyme-linked immunosorbent assay and by their ability to inhibit various activities of the enzyme. The...

Cite
Notton BA, Fido RJ, Galfre G. Monoclonal antibodies to a higher-plant nitrate reductase: Differential inhibition of enzyme activities. Planta. 1985;165(1):114-9doi: 10.1007/BF00392219.
Notton, B. A., Fido, R. J., & Galfre, G. (1985). Monoclonal antibodies to a higher-plant nitrate reductase: Differential inhibition of enzyme activities. Planta, 165(1), 114-9. https://doi.org/10.1007/BF00392219
Notton, B A, et al. "Monoclonal antibodies to a higher-plant nitrate reductase: Differential inhibition of enzyme activities." Planta vol. 165,1 (1985): 114-9. doi: https://doi.org/10.1007/BF00392219
Notton BA, Fido RJ, Galfre G. Monoclonal antibodies to a higher-plant nitrate reductase: Differential inhibition of enzyme activities. Planta. 1985 Jul;165(1):114-9. doi: 10.1007/BF00392219. PMID: 24240965.
Copy Download .nbib Format: NLM
Sulfhydrylated graphene-encapsulated iron nanoparticles directly aminated with polyethylenimine: a novel magnetic nanoplatform for bioconjugation of gamma globulins and polyclonal antibodies.

Journal of materials chemistry. B

Kasprzak A, Poplawska M, Bystrzejewski M, Grudzinski IP.
PMID: 32263356
J Mater Chem B. 2016 Sep 07;4(33):5593-5607. doi: 10.1039/c6tb00838k. Epub 2016 Aug 08.

This study presents for the first time the direct amination of graphene-encapsulated iron nanoparticles (GEINs) with polyethylenimine (PEI) via radical-type reaction. This work describes the first example of a direct addition of N-centered radical species onto the graphene layer....

Cite
Kasprzak A, Poplawska M, Bystrzejewski M, et al. Sulfhydrylated graphene-encapsulated iron nanoparticles directly aminated with polyethylenimine: a novel magnetic nanoplatform for bioconjugation of gamma globulins and polyclonal antibodies. J Mater Chem B. 2016;4(33):5593-5607doi: 10.1039/c6tb00838k.
Kasprzak, A., Poplawska, M., Bystrzejewski, M., & Grudzinski, I. P. (2016). Sulfhydrylated graphene-encapsulated iron nanoparticles directly aminated with polyethylenimine: a novel magnetic nanoplatform for bioconjugation of gamma globulins and polyclonal antibodies. Journal of materials chemistry. B, 4(33), 5593-5607. https://doi.org/10.1039/c6tb00838k
Kasprzak, Artur, et al. "Sulfhydrylated graphene-encapsulated iron nanoparticles directly aminated with polyethylenimine: a novel magnetic nanoplatform for bioconjugation of gamma globulins and polyclonal antibodies." Journal of materials chemistry. B vol. 4,33 (2016): 5593-5607. doi: https://doi.org/10.1039/c6tb00838k
Kasprzak A, Poplawska M, Bystrzejewski M, Grudzinski IP. Sulfhydrylated graphene-encapsulated iron nanoparticles directly aminated with polyethylenimine: a novel magnetic nanoplatform for bioconjugation of gamma globulins and polyclonal antibodies. J Mater Chem B. 2016 Sep 07;4(33):5593-5607. doi: 10.1039/c6tb00838k. Epub 2016 Aug 08. PMID: 32263356.
Copy Download .nbib Format: NLM
The significance of C-reactive protein to albumin ratio in patients with decompensated cirrhosis.

Annals of gastroenterology

Oikonomou T, Goulis I, Kiapidou S, Tagkou N, Akriviadis E, Papatheodoridis G, Cholongitas E.
PMID: 33162744
Ann Gastroenterol. 2020 Nov-Dec;33(6):667-674. doi: 10.20524/aog.2020.0534. Epub 2020 Sep 16.

BACKGROUND: Prognostic indicators in patients with decompensated cirrhosis are vital for the estimation of death risk. The ratio of C-reactive protein to albumin (CAR) has been verified as a prognostic marker in patients with hepatocellular carcinoma and decompensated cirrhosis...

Cite
Oikonomou T, Goulis I, Kiapidou S, et al. The significance of C-reactive protein to albumin ratio in patients with decompensated cirrhosis. Ann Gastroenterol. 2020;33(6):667-674doi: 10.20524/aog.2020.0534.
Oikonomou, T., Goulis, I., Kiapidou, S., Tagkou, N., Akriviadis, E., Papatheodoridis, G., & Cholongitas, E. (2020). The significance of C-reactive protein to albumin ratio in patients with decompensated cirrhosis. Annals of gastroenterology, 33(6), 667-674. https://doi.org/10.20524/aog.2020.0534
Oikonomou, Theodora, et al. "The significance of C-reactive protein to albumin ratio in patients with decompensated cirrhosis." Annals of gastroenterology vol. 33,6 (2020): 667-674. doi: https://doi.org/10.20524/aog.2020.0534
Oikonomou T, Goulis I, Kiapidou S, Tagkou N, Akriviadis E, Papatheodoridis G, Cholongitas E. The significance of C-reactive protein to albumin ratio in patients with decompensated cirrhosis. Ann Gastroenterol. 2020 Nov-Dec;33(6):667-674. doi: 10.20524/aog.2020.0534. Epub 2020 Sep 16. PMID: 33162744; PMCID: PMC7599343.
Copy Download .nbib Format: NLM
Effect of domperidone (leisguard®) on antibody titers, inflammatory markers and creatinine in dogs with leishmaniosis and chronic kidney disease.

Parasites & vectors

Cavalera MA, Gernone F, Uva A, D'Ippolito P, Roura X, Paltrinieri S, Zatelli A.
PMID: 34629081
Parasit Vectors. 2021 Oct 10;14(1):525. doi: 10.1186/s13071-021-05030-8.

BACKGROUND: Immunotherapeutic drugs, such as domperidone, have been shown to be promising treatments against canine leishmaniosis (CanL), but limited data are available. The aim of this pilot study (therapeutic, prospective and non-controlled) was to evaluate the effect of domperidone...

Cite
Cavalera MA, Gernone F, Uva A, et al. Effect of domperidone (leisguard®) on antibody titers, inflammatory markers and creatinine in dogs with leishmaniosis and chronic kidney disease. Parasit Vectors. 2021;14(1):525doi: 10.1186/s13071-021-05030-8.
Cavalera, M. A., Gernone, F., Uva, A., D'Ippolito, P., Roura, X., Paltrinieri, S., & Zatelli, A. (2021). Effect of domperidone (leisguard®) on antibody titers, inflammatory markers and creatinine in dogs with leishmaniosis and chronic kidney disease. Parasites & vectors, 14(1), 525. https://doi.org/10.1186/s13071-021-05030-8
Cavalera, Maria Alfonsa, et al. "Effect of domperidone (leisguard®) on antibody titers, inflammatory markers and creatinine in dogs with leishmaniosis and chronic kidney disease." Parasites & vectors vol. 14,1 (2021): 525. doi: https://doi.org/10.1186/s13071-021-05030-8
Cavalera MA, Gernone F, Uva A, D'Ippolito P, Roura X, Paltrinieri S, Zatelli A. Effect of domperidone (leisguard®) on antibody titers, inflammatory markers and creatinine in dogs with leishmaniosis and chronic kidney disease. Parasit Vectors. 2021 Oct 10;14(1):525. doi: 10.1186/s13071-021-05030-8. PMID: 34629081; PMCID: PMC8504065.
Copy Download .nbib Format: NLM
Showing 25 to 36 of 46 entries